Hainan Bikai Pharmaceutical Co., Ltd.
-
Founded in:
1993-03-22 -
Country:
China -
Address:
No. 10, Yaogu 1st Road, Haikou National High-tech Industrial Development Zone, Hainan Province -
Tax NO.:
91460100284031692C -
Registered Funds:
20 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ru'an Capsules |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
|
189224-26-8 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Curcuma oil |
Broad-spectrum anti-pathogenic microorganisms (anti-fungal, anti-viral, anti-bacterial, anti-mycoplasma and anti-trichomonas), anti-inflammatory, promotes the renewal and repair of inflammatory damaged tissues, promotes the body's immune response, anti-cancer (directly inhibits and destroys cancer cells, anti-HPV to prevent cervical cancer, inhibits abnormal tissue proliferation, and promotes the atrophy of hyperplastic tissue), changes in vaginal cytology in elderly women (estrogen-like effect)
More
Broad-spectrum anti-pathogenic microorganisms (anti-fungal, anti-viral, anti-bacterial, anti-mycoplasma and anti-trichomonas), anti-inflammatory, promotes the renewal and repair of inflammatory damaged tissues, promotes the body's immune response, anti-cancer (directly inhibits and destroys cancer cells, anti-HPV to prevent cervical cancer, inhibits abnormal tissue proliferation, and promotes the atrophy of hyperplastic tissue), changes in vaginal cytology in elderly women (estrogen-like effect) |
8024-37-1 | 1 | |
| Borneol |
The main ingredients of this product are zedoary oil (containing more than 20 chemical components) and borneol, etc. Modern pharmacological research has the following effects: 1. Broad-spectrum anti-pathogenic microorganisms and anti-inflammatory effects: 1. Antifungal effect: It has a strong inhibitory effect on the growth and reproduction of Candida albicans and Candida glabrata; it has antibacterial and inflammatory recovery effects on guinea pig vaginitis infected with Candida albicans. 2. Antiviral effect: This product has a direct inactivation effect on syncytial virus, influenza virus A1 and A3 types and parainfluenza virus type I, and has an inhibitory effect on HPV, Japanese encephalitis virus, and type III adenovirus. 3. Antibacterial effect: It can inhibit the growth and reproduction of Staphylococcus aureus, Staphylococcus epidermidis, α-streptococcus, β-streptococcus, Micrococcus luteus, Neisseria gonorrhoeae, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Corynebacterium vaginalis, Diphtheroids, Bacteroides fragilis, Gastrointestinal bacilli, Salmonella typhi, Vibrio cholerae, etc. 4. Anti-mycoplasma and anti-trichomonas effects: Baofukang suppositories (containing matrix) have a MIC range of 10.00-20.00 mg/ml for mycoplasma (Ureaplasma urealyticum), and a MCC range of 1.25-2.50 mg/ml for vaginal Trichomonas. 5. Anti-inflammatory effect: It has an anti-inflammatory effect on local inflammation in mice caused by croton oil and carrageenan. 2. Promote the renewal and repair of damaged tissues such as inflammation. 3. Promote the body's immune response: Increase the number of leukocytes in peripheral blood vessels and enhance the phagocytic ability of phagocytes. 4. Can cause changes in vaginal cytology in elderly women: Baofukang suppositories do not contain hormones, but have estrogen-like effects. After one week of medication, the patient's vaginal cells change from being mainly bottom cells to being mainly middle cells, and different procedures of surface layers and keratinized cells appear (even if the vaginal mucosa is rejuvenated). 5. Anti-cancer effect: Directly inhibit and destroy cancer cells, but have no effect on normal tissues. It can resist HPV and prevent cervical cancer. Inhibit abnormal tissue proliferation and promote atrophy of hyperplastic tissue.
More
The main ingredients of this product are zedoary oil (containing more than 20 chemical components) and borneol, etc. Modern pharmacological research has the following effects: 1. Broad-spectrum anti-pathogenic microorganisms and anti-inflammatory effects: 1. Antifungal effect: It has a strong inhibitory effect on the growth and reproduction of Candida albicans and Candida glabrata; it has antibacterial and inflammatory recovery effects on guinea pig vaginitis infected with Candida albicans. 2. Antiviral effect: This product has a direct inactivation effect on syncytial virus, influenza virus A1 and A3 types and parainfluenza virus type I, and has an inhibitory effect on HPV, Japanese encephalitis virus, and type III adenovirus. 3. Antibacterial effect: It can inhibit the growth and reproduction of Staphylococcus aureus, Staphylococcus epidermidis, α-streptococcus, β-streptococcus, Micrococcus luteus, Neisseria gonorrhoeae, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Corynebacterium vaginalis, Diphtheroids, Bacteroides fragilis, Gastrointestinal bacilli, Salmonella typhi, Vibrio cholerae, etc. 4. Anti-mycoplasma and anti-trichomonas effects: Baofukang suppositories (containing matrix) have a MIC range of 10.00-20.00 mg/ml for mycoplasma (Ureaplasma urealyticum), and a MCC range of 1.25-2.50 mg/ml for vaginal Trichomonas. 5. Anti-inflammatory effect: It has an anti-inflammatory effect on local inflammation in mice caused by croton oil and carrageenan. 2. Promote the renewal and repair of damaged tissues such as inflammation. 3. Promote the body's immune response: Increase the number of leukocytes in peripheral blood vessels and enhance the phagocytic ability of phagocytes. 4. Can cause changes in vaginal cytology in elderly women: Baofukang suppositories do not contain hormones, but have estrogen-like effects. After one week of medication, the patient's vaginal cells change from being mainly bottom cells to being mainly middle cells, and different procedures of surface layers and keratinized cells appear (even if the vaginal mucosa is rejuvenated). 5. Anti-cancer effect: Directly inhibit and destroy cancer cells, but have no effect on normal tissues. It can resist HPV and prevent cervical cancer. Inhibit abnormal tissue proliferation and promote atrophy of hyperplastic tissue. |
507-70-0 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.
More
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats. |
189224-26-8 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.
More
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats. |
189224-26-8 | 10 |